← hubDrugs

2 sources

← All substances
🔗 MergedCompareTripSitPharmacology

Collated from TripSit, Pharmacology. Where sources differ (e.g. dosing), Compare shows them side by side.

Sections

Also known as bfTS

Potent short-acting opioid and fentanyl analogue. Often dispensed in a nasal spray. This is an highly potent drug - exercise extreme caution. May cause respiratory depression and death in overdose.TS

Oral

Route dataTripSit

ThresholdLightCommonStrongHeavy
400–800 µg800–1500 µg1.5–3 µg—+
01500 µg
LightCommonStrongHeavy
After-effects1–4 hours

Mechanism of actionPH

Butyrfentanyl is a µ opioid receptor agonist similar to fentanyl.

PharmacodynamicsPH

Data for the pharmacodynamics of butyrfentanyl are not readily available.

Pharmacokinetics

Half-lifePH

Data for the half life of butyrfentanyl are not readily available.

AbsorptionPH

Data for the absorption of butyrfentanyl are not readily available.
The route of elimination of butyrfentanyl has not been well described in the literature but most opioids are mainly eliminated in the urine.
Data for the volume of distribution of butyrfentanyl are not readily available.
Data for the clearance of butyrfentanyl are not readily available.

MetabolismPH

Butyrfentanyl can be N-dealkylated to nor-butyrfentanyl by CYP3A4 and CYP2D6, hydroxylated to (ω-1)-hydroxy-butyrfentanyl by CYP3A4, 4'-hydroxylated to 4'-hydroxy-butyrfentanyl, hydroxylated to ω-hydroxy-butyrfentanyl bye CYP2D6 or CYP3A4, or hydroxylated to β-hydroxy-butyrfentanyl by CYP3A4. ω-hydroxy-butyrfentanyl is further metabolized to ω-carboxy-butyrfentanyl while 4'-hydroxy-butyrfentanyl is further metabolized to 4'-hydroxy-3'-methoxy-butyrfentanyl. Many of these metabolites may undergo further conjugation reactions with glucuronic acid or sulfate.

Protein bindingPH

Protein binding studies for butyrfentanyl have not been performed but due to its structural similarity with fentanyl it is likely highly bound to serum albumin and alpha-1-acid glycoprotein in circulation.

Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.